首页> 外国专利> SBHUNC50 POLYPEPTIDE AND SBHUNC50 POLYNUCLEOTIDE

SBHUNC50 POLYPEPTIDE AND SBHUNC50 POLYNUCLEOTIDE

机译:SBHUNC50多肽和SBHUNC50多肽

摘要

PROBLEM TO BE SOLVED: To obtain a new SBHUNC50 polypeptide containing an amino acid sequence having high identity with the whole length of a specific amino acid sequence, and useful in e.g. the treatment, diagnoses of epilepsy, convulsion, megrim, neurodegeneration, psychiatric disorders, etc. SOLUTION: This isolated new polypeptide contains an amino acid sequence having at least 97% identity with the whole length of an amino acid sequence of the formula, being useful for e.g. the treatment and diagnostic assay of dysfunctions or diseases including epilepsy, convulsion, megrim, neurodegeneration, developmental disorders and psychiatric disorders. This new polypeptide is obtained by the following procedure: a polynucleotide obtained, using EST analysis, by the standard cloning and screening, from a cDNA library derived from mRNA such as of human neonatal brain, fetal liver/spleen or T-lymphocytes, is transferred into an expression system followed by expression of the polynucleotide in host cells.
机译:解决的问题:获得一种新的SBHUNC50多肽,其包含与特定氨基酸序列的全长具有高度同一性的氨基酸序列,并且可用于例如解决方案:这种分离出的新多肽包含与该氨基酸序列的全长具有至少97%的同一性的氨基酸序列,非常有用。该化合物可用于治疗,诊断癫痫,惊厥,中枢神经系统疾病,神经退行性疾病,精神病等。例如功能障碍或疾病(包括癫痫,惊厥,中枢神经系统疾病,神经退行性疾病,发育障碍和精神疾病)的治疗和诊断分析。通过以下步骤获得该新多肽:使用EST分析,通过标准克隆和筛选从源自人类新生儿脑,胎儿肝脏/脾脏或T淋巴细胞等mRNA的cDNA文库中获得的多核苷酸被转移进入表达系统,随后在宿主细胞中表达多核苷酸。

著录项

  • 公开/公告号JPH11335397A

    专利类型

  • 公开/公告日1999-12-07

    原文格式PDF

  • 申请/专利权人 SMITHKLINE BEECHAM PLC;

    申请/专利号JP19980363523

  • 申请日1998-12-21

  • 分类号C07K14/47;A61K31/00;A61K35/76;A61K38/00;A61K39/395;A61K45/00;A61K48/00;C07K16/18;C12N15/09;C12P21/02;C12P21/08;G01N33/15;G01N33/50;G01N33/566;G01N33/68;

  • 国家 JP

  • 入库时间 2022-08-22 02:00:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号